About Tamara L Wexler MD, PhD
Tamara L. Wexler, MD, PhD, is an endocrinologist specializing in neuroendocrinology and reproductive endocrinology. She is the Director of the NYU Langone Medical Center Pituitary Center in New York, NY, as well as an Attending in Medicine at Massachusetts General Hospital, Boston, MA.
Dr. Wexler received her medical degree and PhD in neuroscience from the University of Pennsylvania, conducting dissertation research into the pathophysiogy of Kallmann’s Syndrome at the University of Pennsylvania and the National Institutes of Health. She completed her residency in Internal Medicine and her fellowship in Endocrinology, Diabetes and Metabolism at Massachusetts General Hospital, focusing on neuroendocrinology, where she designed and ran national clinical trials.
While remaining on staff at Massachusetts General Hospital, Dr. Wexler worked for four years at McKinsey & Company, where she served as the US Lead for Diabetes and Obesity, Global Lead for other Endocrinology, and as an Expert to McKinsey in Reproductive Health and its R&D, regulatory, clinical, and market dynamics. She continues to independently consult on research and development, focusing on incorporating government, payer, provider, and patient viewpoints in addressing healthcare issues. She reviews grants for the Bill and Melinda Gates Foundation in the area of reproductive health.
She is a member of The Endocrine Society, for which she served on the Advocacy and Public Outreach core committee from 2008-2011. She has served as an invited speaker and moderator at academic medical centers and national conferences. Her publications appear in journals such as Journal of Clinical Endocrinology & Metabolism and Clinical Endocrinology.
Lin E, Wexler TL, Nachtigall L, Tritos N, Swearingen B, Hemphill L, et al. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. Clin Endocrinol. 2012;77(3):430-438.
Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, et al. Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.JCEM. 2010;95(2):567-577.
Wexler TL, Durst R, McCarty D, Picard MH, Gunnell L, Omer Z, et al. Growth hormone status predicts left ventricular mass in patients after cure of acromegaly. Growth Hormone & IGF Research. 2010;20(5):333-337.
Lawson EA, Donoho D, Miller KK, Misra M, Meenaghan E, Lydecker J, Wexler T, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. JCEM. 2009;94(12):4710-4716.
Wexler T, Tunnell L, Omer Z, Kihlthau K, Beauregard C, Graham G, et al. Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. JCEM. 2009;94(7):2471-2477.
Moore AF, Wexler TL, Yung TL, Kish J, Larvie M, Lauter K, et al. An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levels. Endocrine Practice. 2008;14(7):892-897.
Miller KK, Lawson EA, Mathur V, Wexler TL, Meenaghan E, Misra M, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. JCEM. 2007;92(4):1334-1339.
Miller KK, Wexler TL, Zha AM, Lawson EA, Meenaghan E, Misra M, et al. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry. 2007;68(6):959-965.
Renzi MJ, Wexler TL, Raper JA. Olfactory sensory axons expressing a dominant-negative semaphorin receptor enter the CNS early and overshoot their target. Neuron. 2000;28(2):437-447.
Deschenes SM, Walcott JL, Wexler TL, Scherer SS, Fischbeck KH. Altered trafficking of mutant connexin32. J Neurosci. 1997:17(23):9077-9084.
Articles Written by Tamara L Wexler MD, PhD
Financial Disclosures for Tamara L Wexler MD, PhD
EndocrineWeb, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.
To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.
The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.